European Healthtech startup funding raised during H2 2012.
In H2 2012, 37 European Healthtech companies raised a combined €302M across 38 funding rounds, up 35.4% versus H2 2011. Switzerland led by capital raised, and Advent Venture Partners was the most active investor. Data as of 7 Aug 2026.
1 exit.
| €27M |
| Cell Medica | Other | Jul 2012 | €24M |
| GenKyoTex | Series C | Jul 2012 | €21M |
| NeRRe Therapeutics | Series A | Dec 2012 | €14M |
| EarlySense | Series D+ | Nov 2012 | €12M |
| GlySure | Series C | Nov 2012 | €10M |
| CartiHeal | Early VC | Jul 2012 | €7.9M |
| THERAVECTYS | Other | Sep 2012 | €7.5M |
| Biom'Up | Early VC | Oct 2012 | €6.8M |
| NovImmune | Grant | Oct 2012 | €6.0M |
| Cardiosonic | Series B | Dec 2012 | €4.7M |
| Qinec | Series B | Nov 2012 | €1.9M |